Intervention Review

You have free access to this content

Insulin and oral agents for managing cystic fibrosis-related diabetes

  1. Gary M Onady1,*,
  2. Adrienne Stolfi2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 26 JUL 2013

Assessed as up-to-date: 22 JUL 2013

DOI: 10.1002/14651858.CD004730.pub3

How to Cite

Onady GM, Stolfi A. Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD004730. DOI: 10.1002/14651858.CD004730.pub3.

Author Information

  1. 1

    Wright State University, Boonshoft School of Medicine, Dayton, Ohio, USA

  2. 2

    Children's Medical Center, Department of Pediatrics, Dayton, Ohio, USA

*Gary M Onady, Boonshoft School of Medicine, Wright State University, Room 105, Medical Sciences Building, 3640 Colonel Glenn Highway, Dayton, Ohio, OH 45435, USA.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 26 JUL 2013


Cited in:


This article has been cited by:

  1. 1
    María Martín-Frías, Raquel Barrio, Diet and Exercise in Cystic Fibrosis, 2015,


  2. 2
    Marie-Terese Caraher, Sally Marshall, Cystic fibrosis related diabetes – causes, impact on health and management of patients, European Diabetes Nursing, 2014, 11, 3
  3. 3
    S. Perano, C.K. Rayner, J. Couper, J. Martin, M. Horowitz, Cystic fibrosis related diabetes—a new perspective on the optimal management of postprandial glycemia, Journal of Diabetes and its Complications, 2014, 28, 6, 904